Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.

Masvidal L, Iniesta R, Casalà C, Galván P, Rodríguez E, Lavarino C, Mora J, de Torres C.

PLoS One. 2013;8(3):e59762. doi: 10.1371/journal.pone.0059762. Epub 2013 Mar 22.

2.

The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.

Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodríguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J, de Torres C.

Carcinogenesis. 2013 Feb;34(2):268-76. doi: 10.1093/carcin/bgs338. Epub 2012 Oct 29.

PMID:
23108190
3.

The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.

de Torres C, Beleta H, Díaz R, Toran N, Rodríguez E, Lavarino C, García I, Acosta S, Suñol M, Mora J.

Cancer. 2009 Jun 15;115(12):2792-803. doi: 10.1002/cncr.24304.

4.

Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor.

Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN, Cole DE.

J Clin Endocrinol Metab. 2004 Nov;89(11):5634-8.

PMID:
15531522
5.

A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis.

Chou YH, Woon PY, Chen WC, Hsu YW, Chang JM, Hwang DY, Chiu YC, Kuo HC, Chang WP, Hou MF, Liu ME, Chang JG, Chang WC.

PLoS One. 2011;6(9):e25227. doi: 10.1371/journal.pone.0025227. Epub 2011 Sep 22.

6.

Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors.

Masvidal L, Iniesta R, García M, Casalà C, Lavarino C, Mora J, de Torres C.

Mol Carcinog. 2017 Apr;56(4):1281-1289. doi: 10.1002/mc.22589. Epub 2016 Nov 24.

PMID:
27862333
7.

Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region.

Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E, Soldati L; GENIAL network (Genetics and Environment in Nephrolithiasis Italian Alliance)..

Nephrol Dial Transplant. 2010 Jul;25(7):2245-52. doi: 10.1093/ndt/gfp760. Epub 2010 Jan 12.

PMID:
20067903
8.

The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.

Eren PA, Turan K, Berber I, Canbakan M, Kara M, Tellioglu G, Bugan U, Sevinç C, Turkmen F, Titiz MI.

Clin Nephrol. 2009 Aug;72(2):114-21.

PMID:
19640368
9.

Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics.

Yun FH, Wong BY, Chase M, Shuen AY, Canaff L, Thongthai K, Siminovitch K, Hendy GN, Cole DE.

Clin Biochem. 2007 May;40(8):551-61. Epub 2007 Jan 18.

PMID:
17320849
10.

Polymorphisms of CASR gene increase the risk of primary hyperparathyroidism.

Wang XM, Wu YW, Li ZJ, Zhao XH, Lv SM, Wang XH.

J Endocrinol Invest. 2016 Jun;39(6):617-25. doi: 10.1007/s40618-015-0405-5. Epub 2015 Dec 28.

PMID:
26710757
11.

Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India.

Guha M, Bankura B, Ghosh S, Pattanayak AK, Ghosh S, Pal DK, Puri A, Kundu AK, Das M.

PLoS One. 2015 Jun 24;10(6):e0130790. doi: 10.1371/journal.pone.0130790. eCollection 2015.

12.

[Effect of interleukin-6 and calcium sensing receptor gene polymorphisms on bone mass accrual in Chinese adolescent girls].

Li X, He GP, Su YX.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Apr;25(2):136-40. Chinese.

PMID:
18393231
13.

Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients.

Ferreira LG, Pereira AC, Heilberg IP.

Nephron Clin Pract. 2010;114(2):c135-44. doi: 10.1159/000254386. Epub 2009 Nov 3.

PMID:
19887834
14.

Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.

Shui IM, Mucci LA, Wilson KM, Kraft P, Penney KL, Stampfer MJ, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):118-26. doi: 10.1158/1055-9965.EPI-12-0670-T. Epub 2012 Nov 2.

15.

Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns.

Laaksonen MM, Outila TA, Karkkainen MU, Kemi VE, Rita HJ, Perola M, Valsta LM, Lamberg-Allardt CJ.

J Nutrigenet Nutrigenomics. 2009;2(2):55-63. doi: 10.1159/000204960. Epub 2009 Feb 27.

PMID:
19690432
16.

Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: a comprehensive gene analysis.

Shakhssalim N, Kazemi B, Basiri A, Houshmand M, Pakmanesh H, Golestan B, Eilanjegh AF, Kashi AH, Kilani M, Azadvari M.

Scand J Urol Nephrol. 2010 Dec;44(6):406-12. doi: 10.3109/00365599.2010.497770. Epub 2010 Jul 5.

PMID:
20602573
17.

Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population.

Bácsi K, Hitre E, Kósa JP, Horváth H, Lazáry A, Lakatos PL, Balla B, Budai B, Lakatos P, Speer G.

BMC Cancer. 2008 Nov 3;8:317. doi: 10.1186/1471-2407-8-317.

18.

R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria.

Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G, Soldati L.

Kidney Int. 2007 Jun;71(11):1155-62. Epub 2007 Feb 28.

19.

Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients.

Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML.

J Am Soc Nephrol. 2002 Oct;13(10):2517-23.

20.

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.

Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC.

J Natl Cancer Inst. 1995 Oct 4;87(19):1470-6.

PMID:
7674334

Supplemental Content

Support Center